Literature DB >> 25800764

Targeting tumor hypoxia with hypoxia-activated prodrugs.

Jen Jen Yeh1, William Y Kim2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25800764     DOI： 10.1200/JCO.2014.60.0759

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  14 in total

1.  Micropharmacology: An In Silico Approach for Assessing Drug Efficacy Within a Tumor Tissue.

Authors:  Aleksandra Karolak; Katarzyna A Rejniak
Journal:  Bull Math Biol       Date:  2018-02-08       Impact factor: 1.758

2.  Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients.

Authors:  Yuebi Hu; Ryan S Alden; Justin I Odegaard; Stephen R Fairclough; Ruthia Chen; Jennifer Heng; Nora Feeney; Rebecca J Nagy; Jayshree Shah; Bryan Ulrich; Martin Gutierrez; Richard B Lanman; Judy E Garber; Cloud P Paweletz; Geoffrey R Oxnard
Journal:  Clin Cancer Res       Date:  2017-09-25       Impact factor: 12.531

3.  Iontophoretic device delivery for the localized treatment of pancreatic ductal adenocarcinoma.

Authors:  James D Byrne; Mohammad R N Jajja; Allison N Schorzman; Amanda W Keeler; J Christopher Luft; William C Zamboni; Joseph M DeSimone; Jen Jen Yeh
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

4.  Hypoxia-inducible lentiviral gene expression in engineered human macrophages.

Authors:  Harrison K Chinn; Jennifer L Gardell; Lisa R Matsumoto; Kevin P Labadie; Tara N Mihailovic; Nicole A P Lieberman; Amira Davis; Venu G Pillarisetty; Courtney A Crane
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

Review 5.  Emerging targets for radioprotection and radiosensitization in radiotherapy.

Authors:  Sumit Kumar; Rajnish Kumar Singh; Ramovatar Meena
Journal:  Tumour Biol       Date:  2016-06-19

Review 6.  Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies.

Authors:  Josh W DiGiacomo; Daniele M Gilkes
Journal:  Target Oncol       Date:  2018-04       Impact factor: 4.493

7.  Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer.

Authors:  Milan Grkovski; Nancy Y Lee; Heiko Schöder; Sean D Carlin; Bradley J Beattie; Nadeem Riaz; Jonathan E Leeman; Joseph A O'Donoghue; John L Humm
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05-24       Impact factor: 9.236

Review 8.  Hypoxia, Epithelial-Mesenchymal Transition, and TET-Mediated Epigenetic Changes.

Authors:  Shih-Han Kao; Kou-Juey Wu; Wen-Hwa Lee
Journal:  J Clin Med       Date:  2016-02-04       Impact factor: 4.241

Review 9.  No patient left behind: The promise of immune priming with epigenetic agents.

Authors:  Corey A Carter; Bryan T Oronsky; Joseph Roswarski; Arnold L Oronsky; Neil Oronsky; Jan Scicinski; Harry Lybeck; Michelle M Kim; Michelle Lybeck; Tony R Reid
Journal:  Oncoimmunology       Date:  2017-08-30       Impact factor: 8.110

10.  Leveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid Tumors.

Authors:  Danika Lindsay; Colleen M Garvey; Shannon M Mumenthaler; Jasmine Foo
Journal:  PLoS Comput Biol       Date:  2016-08-25       Impact factor: 4.475
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.